Markets:

Overview

News

Currencies

International

Treasuries

LifeMD, Inc. - Common Stock (NQ:LFMD)

3.500 -0.230 (-6.17%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LifeMD, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

What's going on in today's after hours session ↗

March 10, 2025

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗

March 10, 2025

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir...

Via Benzinga

Topics Economy Stocks

Earnings Scheduled For March 10, 2025 ↗

March 10, 2025

Via Benzinga

Recap: LifeMD Q4 Earnings ↗

March 11, 2024

Via Benzinga

Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session. ↗

February 21, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Gapping stocks in Friday's session ↗

February 21, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Can the New CEO Revive This Struggling Telehealth Stock?

July 24, 2024

Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023

Via MarketBeat

Topics Earnings

Earnings Outlook For LifeMD ↗

March 08, 2024

Via Benzinga

$100 Invested In LifeMD 5 Years Ago Would Be Worth This Much Today ↗

January 19, 2024

Via Benzinga

3 Overlooked Telehealth Stocks Poised for a Comeback ↗

July 16, 2024

Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 10, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2024

Via Benzinga

Hims & Hers Health Soars on Generic GLP-1 Rollout Plans

June 03, 2024

Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments

Via MarketBeat

LifeMD Can Surge on Its GLP-1 Offerings

May 28, 2024

LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result

Via MarketBeat

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 09, 2024

Via Benzinga

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

May 09, 2024

Via Benzinga

LFMD Stock Earnings: LifeMD Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

LFMD stock results show that LifeMD beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 ↗

April 30, 2024

On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.

Via Investor's Business Daily

Dexcom Stock Continues To Post Very Healthy Profits, Returns ↗

April 30, 2024

Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday.

Via Investor's Business Daily

Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating ↗

April 25, 2024

On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.

Via Investor's Business Daily

Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good. ↗

March 26, 2024

Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.

Via Investor's Business Daily

Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗

March 19, 2024

The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.

Via Investor's Business Daily

LifeMD Shares Come Back to Life on GLP-1 Business Growth

March 19, 2024

LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024

Via MarketBeat

DexCom Stock Trying To Close In On Key Technical Benchmark ↗

March 18, 2024

In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.

Via Investor's Business Daily

3 Stocks That Could Benefit from the Rise of Telemedicine ↗

March 14, 2024

With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around.

Via InvestorPlace

Can WeightWatchers Regain its Mojo after Oprah Steps Down?

March 13, 2024

WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).

Via MarketBeat

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 11, 2024

Via Benzinga

Earnings Scheduled For March 11, 2024 ↗

March 11, 2024

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.

Via Benzinga

Hey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term Gains ↗

March 07, 2024

These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks.

Via InvestorPlace

Hims & Hers Stock Rises On Stimulating Earnings Growth

March 05, 2024

Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience

Via MarketBeat

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.